Collagen Solutions plc provided earnings guidance for the ending March 31, 2020. The company expects the loss for the year will be materially greater than anticipated due to increased costs from a development and manufacturing contract which has taken longer than originally anticipated. The Company is facing multiple uncertainties that may also impact year-end revenue, pushing some sales into the next financial year. These include: closing certain contracts in late-stage discussions, and delivery of collagen and tissue products for which the Company has already received orders.